0001567619-23-005926.txt : 20230508 0001567619-23-005926.hdr.sgml : 20230508 20230508103101 ACCESSION NUMBER: 0001567619-23-005926 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230508 DATE AS OF CHANGE: 20230508 EFFECTIVENESS DATE: 20230508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-481052 FILM NUMBER: 23896373 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 D 1 primary_doc.xml X0708 D LIVE 0001070081 PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ NEW JERSEY 07080-2449 9082227000 DELAWARE None PTC THERAPEUTICS INC Corporation true Matthew B. Klein, M.D. c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Executive Officer Director Dr. Klein is the Chief Executive Officer and the Director of the Development Committee of the Issuer. Neil Almstead, Ph.D c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Executive Officer Dr. Almstead is the Chief Technical Operations Officer of the Issuer. Mark E. Boulding c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Executive Officer Mr. Boulding is the Executive Vice President and Chief Legal Officer of the Issuer. Emily Hill c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Executive Officer Ms. Hill is the Chief Financial Officer of the Issuer. Eric Pauwels c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Executive Officer Mr. Pauwels is the Chief Business Officer of the Issuer. Christine Utter c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Executive Officer Ms. Utter is the Senior Vice President, Chief Accounting Officer and Head of People Services of the Issuer. Stepanie S. Okey c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Director Jerome B. Zeldis, M.D., Ph.D. c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Director Emma Reeve c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Director Michael Schmertzler c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Director Glenn D. Steele Jr., M.D., Ph.D. c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Director Mary Smith c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Director Allan Jacobson, Ph.D. c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Director David P. Southwell c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Director Alethia Young c/o PTC Therapeutics, Inc. 100 Corporate Court South Plainfield NJ NEW JERSEY 07080 Director Biotechnology Decline to Disclose 06b false 2023-04-10 false true true Common Stock true 0 35897425 35897425 0 false 40 0 0 0 false PTC THERAPEUTICS, INC. /s/ Mark E. Boulding Mark E. Boulding Executive Vice President and Chief Legal Officer 2023-05-05